APA (7th ed.) Citation

Yokota, S., Kamei, K., Fujinaga, S., Hamada, R., Inaba, A., Nishi, K., . . . Ito, S. (2024). Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: A multicenter study. Pediatric Nephrology, 39(10), 2979. https://doi.org/10.1007/s00467-024-06422-5

Chicago Style (17th ed.) Citation

Yokota, Shunsuke, et al. "Efficacy of Rituximab and Risk Factors for Poor Prognosis in Patients with Childhood-onset Steroid-resistant Nephrotic Syndrome: A Multicenter Study." Pediatric Nephrology 39, no. 10 (2024): 2979. https://doi.org/10.1007/s00467-024-06422-5.

MLA (9th ed.) Citation

Yokota, Shunsuke, et al. "Efficacy of Rituximab and Risk Factors for Poor Prognosis in Patients with Childhood-onset Steroid-resistant Nephrotic Syndrome: A Multicenter Study." Pediatric Nephrology, vol. 39, no. 10, 2024, p. 2979, https://doi.org/10.1007/s00467-024-06422-5.